Skip to main content
. 2014 Jul 30;12(9):1103–1135. doi: 10.1586/14787210.2014.940900

Table 2.

Quality of the evidence, in aggregate, supporting single-dose doxycycline for Lyme disease prophylaxis.

No. of studies Limitations Imprecision Inconsistency Indirectness Quality
1 Inappropriate surrogate (EM)
Insufficient duration of observation
Insufficient reporting of negative treatment-associated outcomes
Few events
Wide CI
Unsupported assumption regarding outcomes in dropouts
Non-replicated in humans
Inconsistent with animal model
Not applicable to patients bitten by species other than Ixodes scapularis
Not applicable to patients exposed to multiple tick-borne diseases
Efficacy not applicable to other antibiotics
Effectiveness findings applicable to prevention of EM only and not other, non-EM presentations
Very low

EM: Erythema migrans.